Large-scale testing (Phase 3)Study completedNCT01207011What this trial is testingAmrubicin (AMR) Trial in Patients With Non-small Cell Lung CancerWho this might be right forLung Cancer Sumitomo Pharma Co., Ltd. 202
Large-scale testing (Phase 3)Study completedNCT02477644What this trial is testingPlatine, Avastin and OLAparib in 1st LineWho this might be right forOvarian Cancer Arcagy Research 806
Testing effectiveness (Phase 2)UnknownNCT05298020What this trial is testingEnvafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic CancerWho this might be right forAdvanced Pancreatic Cancer The Affiliated Hospital of Xuzhou Medical University 20
Testing effectiveness (Phase 2)Study completedNCT00285389What this trial is testingTreatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 YearsWho this might be right forMantle Cell Lymphoma French Innovative Leukemia Organisation 39
Large-scale testing (Phase 3)UnknownNCT04500717What this trial is testingAlmonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene MutationWho this might be right forNon Small Cell Lung Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 460
Testing effectiveness (Phase 2)Ended earlyNCT03524820What this trial is testingCetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal CancerWho this might be right forCancer of Colon Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Ended earlyNCT05215951What this trial is testingOsimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCWho this might be right forLung Cancer AstraZeneca 4
Large-scale testing (Phase 3)Study completedNCT00820755What this trial is testingTrial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer (NSCLC) Merck KGaA, Darmstadt, Germany 583
Testing effectiveness (Phase 2)Study completedNCT04834674What this trial is testingDEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00687440What this trial is testingDetermine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)Who this might be right forBreast Neoplasm Merck Sharp & Dohme LLC 27
Early research (Phase 1)UnknownNCT05942508What this trial is testingA Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyWho this might be right forLimited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy Jinming Yu 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025850What this trial is testingEfficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal CancerWho this might be right forColorectal Carcinoma Fudan University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531291What this trial is testingSurufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine DifferentiationWho this might be right forESCCBiliary Tract CancerGastric Cancer+1 more RenJi Hospital 80
Testing effectiveness (Phase 2)UnknownNCT05741021What this trial is testingA Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung CancerNSCLCPD-1 Shandong New Time Pharmaceutical Co., LTD 84
Testing effectiveness (Phase 2)Looking for participantsNCT07570849What this trial is testingChidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma Shanghai Zhongshan Hospital 35
Large-scale testing (Phase 3)UnknownNCT04203485What this trial is testingCamrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forPD-L1 Positive Non-small Cell Lung Cancer Jiangsu HengRui Medicine Co., Ltd. 762
Large-scale testing (Phase 3)Active Not RecruitingNCT05722015What this trial is testingSubcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)Who this might be right forMetastatic Non-small Cell Lung Cancer Merck Sharp & Dohme LLC 377
Testing effectiveness (Phase 2)Active Not RecruitingNCT05844150What this trial is testingPM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLCWho this might be right forSCLC Biotheus Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT02095782What this trial is testingChemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor MutationWho this might be right forNon-small-cell Lung Cancer Guangdong Association of Clinical Trials 10
Large-scale testing (Phase 3)Active Not RecruitingNCT03504397What this trial is testingCompare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.